Saliva plays an important role in the protection of oral cavity and alterations in either salivary fl ow rate or protein composition may have dramatic effects on oral health. Prevention and management of oral complications of cancer and cancer therapy will improve oral function and quality of life, and reduce morbidity and the cost of care. The aim of this study was to investigate the saliva of patients with breast cancer biochemically and cytologically and compare with healthy controls. Accordingly, lipid peroxidation (LPO), total protein, salivary fl ow rate, and pH levels were measured in the saliva samples obtained from 20 breast cancer patients and 11 healthy individuals. Tissue factor (TF) is a major regulator of normal hemostasis and thrombosis, and TF activity of saliva samples was evaluated. Under the conditions used, patients with breast cancer present a signifi cant reduction in total protein, pH and LPO levels. Salivary TF activity was higher in breast cancer patients than that in control subjects, but the degree of increase was not statistically signifi cant. In addition, the analysis of saliva samples by SDS polyacrylamide gel electrophoresis showed the retarded mobility of the 66-kDa proteins and the increased proteins of about 36 kDa in the patient group. Some patients with breast cancer had increased number of leucocytes. Importantly, dysplastic cells and yeast cells were detected only in saliva samples of cancer patients. Decreased salivary LPO may be considered as a risk factor for breast cancer. breast cancer; saliva; tissue factor; lipid peroxidation; protein.
expressed in a wide range of cancer cells and plays important roles in cancer progression and metastasis (Ueno et al. 2000) , we hypothesized that salivary TF activity may also change in breast cancer patients and this may contribute to the oral complications. Therefore the aim of this study was to evaluate TF activity, pH, salivary fl ow rate, total protein of saliva samples obtained from breast cancer patients and healthy individuals. Moreover, saliva imprint samples were evaluated cytologically. In addition since saliva is reported to be suitable to detect the body's oxidative stress level (Arana et al. 2006) , lipid peroxidation (LPO) levels were determined in saliva samples. Saliva samples were also examined electrophoretically.
MATERIALS AND METHODS

Saliva
Included in this study were 20 breast cancer patients with average age of 52 years with varying histological diagnoses. Samples were taken during chemotherapy application and chemotherapy was designed in adjuvant, neoadjuvant and palliative settings. General characteristics of the patients and drugs included in chemotherapy combinations are given in Table 1 . The control group consisted of 11 healthy women with average age of 45 years having no systemic disease or history of breast cancer. Breast cancer patients were selected from individuals who attended Istanbul University Medical Faculty Oncology Department and control subjects from Marmara University, Faculty of Dentistry. Saliva samples were collected in restful and quiet circumstances. All subjects gave informed consent to participate in the study. Unstimulated mixed saliva samples were collected, after overnight fasting, before breakfast, at the time interval 08 : 00-10 : 00, and after the mouth had been rinsed with distilled water, by spitting into a funnel. Saliva volume and collection time were recorded to calculate salivary fl ow rate. Saliva samples were centrifuged (3,000 rpm for 5 min) and LPO and total protein concentrations were determined in the supernatant. On the other hand, saliva samples were not centrifuged for TF activity and cytological examinations but they were vortexed at least 10 sec for easy sampling. Saliva samples were analyzed for pH by using pH paper (Neutralit pH 5.5-9.0, with graduation 0.5 Merck-pH Indikatepapier). exacerbation of dental or periodontal disease, caries or demineralization risk, gingivitis and taste disturbance. Therefore, prevention and management of oral complications of cancer and cancer therapy will improve oral function and quality of life, and reduce morbidity and the cost of care. Oral assessment, and oral and dental care have been strongly recommended before cancer therapy and should be continued during and after cancer therapy (National Institutes of Health Consensus Development Conference on Oral Complications of Cancer Therapies 1990; Epstein et al. 2001; Miller et al. 2001; Sonis et al. 2001) .
Tissue factor (TF), also known as thromboplastin or Factor III, is considered to be a major regulator of normal hemostasis and thrombosis (Nemerson 1995; Marutsuka et al. 2005) . TF is an essential initiator of the coagulation cascade and is expressed during various stages of atherosclerotic lesions (Marutsuka et al. 2005) . Together with the proteolytic enzyme factor VIIa, TF sequentially activates factor X and prothrombin, leading to fi brin deposition and formation of a blood clot. Although the role of TF in coagulation-unrelated events such as infl ammation, sepsis, and angiogenesis is extensively investigated, the role of TF in tumor invasion and metastasis has undoubtedly attracted most attention because of its obvious clinical relevance (Versteeg et al. 2004) . Various tissues and body fl uids (amniotic fl uid, bile, semen, sweat, or tears) have been known to have TF activity (Zacharski 1979; Price et al. 2004; Yarat et al. 2004; Alturfan et al. 2006; Emekli-Alturfan 2007) . However, most of them are not easily obtained, saliva, on the other hand, is especially suitable for study because of its ready availability.
Diagnosis of disease via the analysis of saliva is potentially valuable since collection of the fl uid is associated with fewer compliance problems as compared with the collection of blood. Moreover, the use of a saliva-based test could prove very useful in post-operative and/or adjunctive therapy management of breast cancer patients (Bigler et al. 2002) . To our knowledge, there is no study in the literature investigating salivary TF activity in breast cancer patients. Since TF is
Assay of tissue factor activity
Tissue factor activities of saliva samples were determined according to Quick's one stage method (Ingram and Hills 1976 ) using normal plasma. This was performed by mixing 0.1 ml saliva with 0.1 ml of 0.02 M CaCl 2 , with the clotting reaction being started on addition of 0.1 ml of plasma. All reagents were brought to the reaction temperature (37°C) before admixture. Since the clotting time is inversely proportional to the tissue factor activity, the lengthening of the clotting time is a manifestation of decreased TF activity.
Biochemical assays
Total protein content of saliva samples were evaluated by the method of Lowry (Lowry et al. 1951) . LPO was assayed by measuring malondialdehyde (MDA) levels in saliva. MDA levels in saliva were determined as thiobarbituric acid reactive substances (TBARS) according to the method of Yagi (1984) . Electrophoretic examination of saliva proteins was carried out by Laemmli SDS-polyacrylamide gel electrophoresis (Laemmli 1970) .
Cytological examinations
For cytological examinations saliva samples were smeared over a glass microscope slide and fi xed with air. Then they were stained with Giemsa stain and microscopically examined for the presence of epithelial cells, leucocytes, bacteria, and dyplastic and yeast cells (Atay and Topalidis 1994) .
Statistical analysis
Data are presented as mean ± standard deviation. The differences between the values of the groups were tested by Student t-test and Wilcoxon signed-rank test. Differences with p values of 0.05 or less were considered signifi cant. Statistical analysis was performed with the SPSS software for Windows, Version 11.
RESULTS
Total protein, LPO levels and pH values of breast cancer patients were signifi cantly lower than those of healthy controls ( p < 0.05). No signifi cant differences were observed between salivary fl ow rates of breast cancer patients and the healthy controls. Salivary TF activity was higher in breast cancer patients than that in the control group, but the difference was not statistically signifi cant (Table 2) .
No signifi cant differences were found between breast cancer patients and healthy controls regarding epithelial cells, leucocytes, bacteria, dysplastic cells and yeast cells (Table 3 ). The 
C and P represent control group and patient group respectively; the numbers represent the subjects in the group. Letters Moreover many yeast cells were detected in the saliva imprint sample of one patient (P14) and scarce yeast cells were observed in four patients with breast cancer (P9, P16, P17, P19) (Table 3 ).
In the control group, 7 subjects had leuco- Control group (n = 11) Breast cancer group * (n = 20)
Epithelial cells 1 54.5% (n = 6) 20% (n = 4) 2 45.5% (n = 5) 80% (n = 16) Leucocytes 0 36.4% (n = 4) 40% (n = 8) 1 63.6% (n = 7) 15% (n = 3) 2 0% 45% (n = 9) Dysplastic cells 0 100% (n = 11) 75% (n = 15) 1 0% 25% (n = 5) Bacteria 1 27.3% (n = 3) 20% (n = 4) 2 72.7% (n = 8) 80% (n = 16) Yeast cells 0 100% (n = 11) 75% (n = 15) 1 0% 20% (n = 4) 2 0% 5% (n = 1)
Wilcoxon signed-rank test was used to estimate the difference between groups. *p *p * > 0.05, epithelial, leucocyte, dysplastic, bacteria and yeast cells were not signifi cantly different in breast cancer patients. P4, P7, P12, P13 and P15 had dysplastic cells. P9, P16, P17, P19 had scarce yeast cells where P14 had many yeast cells. P represents the patient group; the numbers represent the subjects in the group. cytes in the normal range where 4 subjects had no leucocytes in their saliva imprint samples. On the other hand, 3 patients with breast cancer had leucocytes in the normal range where 9 patients had increased number of leucocytes in their saliva imprint samples (Table 3 , Fig. 1 ). The analysis of saliva proteins by SDS polyacrylamide gel electrophoresis revealed the noticeable differences between healthy controls and breast cancer patients (Fig. 3) . The patients group showed the retarded mobility of the 66-kDa proteins and the increased proteins of about 36 kDa.
DISCUSSION
Screening for breast cancer has been shown to reduce breast cancer mortality (Bigler et al. 2002) . Salivary biomarkers have been identifi ed that may provide diagnostic information about a variety of cancers and other diseases. In particular, proof-of-principle has been demonstrated for sali- Table 1 . The patients group showed an increased set of bands that correspond to the molecular weight region above 66 kDa and in 36 kDa (black arrow).
vary c-erbB-2, whose elevation has been shown to correlate strongly with breast malignancy in women (Strecfus and Bigler 2005) . As the principal biological initiator of blood coagulation, TF is believed to play a critical role in thrombosis and thrombogenesis (Nemerson 1995; Marutsuka et al. 2005 ) and concentrations in several biological fl uids correlate with different pathological conditions (Fareed et al. 1995) . TF is expressed in a wide range of cancer cells and plays important roles in cancer progression and metastasis. Recently, the intracellular function of TF has been revealed to be involved in cancer invasion, independent of the blood coagulation pathway (Ueno et al. 2000) . Ueno et al. (2000) showed an up-regulation of plasma TF concentration in breast cancer patients compared with controls. Moreover in their study, the concentration of plasma TF was associated with tissue TF expression in both tumour and stroma.
Saliva has long been recognized as having thromboplastic properties (Bellis and Scott 1933; Ersner et al. 1934; Glazko and Greenberg 1939; Noun-Eldin and Wilkonson 1957; Doku and Taylor 1962; Zacharski and Rosenstein 1979; Yarat et al. 2004 ). However, our study is the only one in the literature, which evaluated salivary TF activity in patients with breast cancer. Salivary TF activity of breast cancer patients did not change signifi cantly when compared with the controls. This is relevant to the cytological examination of saliva samples where no differences were observed in salivary cells between breast cancer patients and the controls, since approximately 78% of salivary TF activity is attributed to cells found in saliva (Zacharski and Rosenstein 1979) .
On the other hand, although statistically insignifi cant, TF activity was found to be increased compared with the control group. We may suppose that the results could be more signifi cant if patients were with similar histological diagnoses and stages of carcinoma of the breast. Since patients with breast cancer were having adjuvant, neoadjuvant and palliative therapy, we assume that changed salivary TF activity can be due to these therapies. However, Auger and Mackie (1988) investigated the effects of tamoxifen on blood coagulation in patients with clinically localized breast carcinoma. They reported that, tamoxifen did not induce signifi cant changes in parameters of coagulation (antithrombin III, protein C, fi brinopeptide A and in vitro monocyte procoagulant activity) to account for the reported thromboembolic events associated with this therapy. Therefore the increased TF activities in breast cancer patients may represent the net effects caused by cancer itself. However we believe that investigation of the effects of specifi c therapies on TF activity may illuminate this debate.
Total protein, LPO levels and pH values of breast cancer patients were signifi cantly lower than that of healthy controls. Hannig et al. (2006) compared the relative amount of low molecular weight salivary proteins in patients with head and neck tumours treated with radiotherapy and healthy subjects. They found signifi cantly reduced fraction of acidic proline-rich proteins compared with non-irradiated healthy subjects. On the other hand, Makkonen et al. (1986) analyzed the radiation-induced changes in the fl ow rate and protein composition of stimulated whole saliva in eleven patients treated for malignant conditions of the head and neck. They observed unusually high salivary concentrations of albumin, lactoferrin, lysozyme, salivary peroxidase, myeloperoxidase, and total protein during the therapy, but most values slowly returned to pretreatment levels after cessation of radiation. They concluded that the observed qualitative changes in whole saliva components were net effects caused by the cancer itself, radiation therapy given, systemic diseases, or medications, as well as mucosal infl ammations.
The observation of electrophoregrams of total saliva samples of patients with cancer showed notable differences in some protein bands, compared with the control group (Fig. 3) . Under our experimental conditions, the saliva samples of patients group showed the retarded mobility of the 66-kDa proteins and the increased proteins of about 36 kDa, which led us to infer that the proteins of 66 kDa can undergo a process that causes an increase in their molecular mass or changes in their synthesis or post-translational changes. Since up-regulation of plasma TF concentration has been shown in breast cancer patients, increased bands in the saliva of breast cancer patients, may correspond to increased TF since TF is a 47 kDa glycoprotein (Lopes-Bezerra and Filler 2003) .
Coagulation disorders have been associated with the use of chemotherapeutic drugs. Walsh et al. (1992) suggested that membrane alterations, which occur following treatment with DNA/RNA intercalating drugs such as cisplatin and adriamycin (doxorubicin), may result in a highly active form of monocyte/macrophage TF, thereby contributing to the complications caused by activated coagulation. Accordingly in the present study, patients who received epirubicin (P15 and P17) which is an antineoplastic agent derived from doxorubicin, showed an increased set of bands in the molecular weight region about 36 kDa, that may correspond to increased TF (Fig. 3 ). Moreover these patients had periodontal disease which is chronic Gram-negative infection, and secondary Gram-negative infections were reported to contribute to the procoagulant potential of these cytotoxic drugs (Walsh et al. 1992) .
On the other hand, zinc-α 2-glycoprotein is a 41-kDa protein present in saliva, and is secreted by a variety of normal and malignant epithelial cells and overexpression by tumors has been implicated in cancer cachexia (Schenkels et al. 1995; Hale 2002) . Therefore increased bands m a y a l s o c o r r e s p o n d t o i n c r e a s e d z i n c -α 2-glycoprotein in breast cancer patients. However, detailed analysis of the bands is necessary to decide on the exact protein.
Our results suggest no signifi cant differences between breast cancer patients and healthy controls regarding epithelial cells, leucocytes, bacteria, dysplastic cells, and yeast cells. However, dysplastic cells and yeast cells were present (Table  3 , Fig. 2 ) and leucocytes were increased in saliva imprint samples of breast cancer patients (Fig. 1) .
Cellular oxidants, called reactive oxygen species (ROS), are constantly produced in animal and human cells. Lipid peroxidation is probably the most extensively investigated free radicalinduced process. Data support the notion that increased formation of ROS may play an important role in carcinogenesis, atherosclerosis, diabetes, emphysema, cataracts, and neurodegenerative diseases (Sodergren 2000; Salganik 2001 ). However, accumulating data suggest that ROS not only act as damaging entities but also may carry out important benefi cial functions. ROS seem to be mediators or triggers of protective mechanisms, such as apoptosis, phagocytosis, and detoxifi cation reactions. Among these mechanisms, apoptosis, which eliminates precancerous and cancerous cells, is particularly important (Salganik 2001) . Moreover, Gago-Dominguez et al. (2005) suggested the possibility that decreased lipid peroxidation may be a mechanism responsible, at least in part, for the increased risk associated with several hormonal and nonhormonal risk factors for breast cancer. This may be one of the reasons for the decreased salivary lipid peroxidation observed in breast cancer patients in our study.
CONCLUSION
We conclude that patients with breast cancer present a signifi cant reduction of total protein, pH and LPO levels. The patients group showed the retarded mobility of the 66-kDa proteins and the increased proteins of about 36 kDa. Further studies investigating the effects of different types of chemotherapies including patients with the different stages of the disease are necessary.
